Prospective study shows advanced lipoprotein profiling does not surpass standard lipid testing for cardiovascular risk in women, indicating limited clinical utility for routine screening.
In this prospective study of healthy women, cardiovascular disease risk prediction associated with lipoprotein profiles evaluated by NMR was comparable but not superior to that of standard lipids or apolipoproteins.
No takes yet. Share an insight, caveat, or question.
Mora et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: